Submitted by Anonymous (not verified) on 12 May 2025 - 14:00
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised